Zentalis Pharmaceuticals, Inc. - COM (ZNTL)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
76.6M
Holdings value Q2 2024
$313M
Value change Q2 2024
-$53.7M
Grand Portfolio weight change Q2 2024
0%
Number of holders
140
Number of buys Q2 2024
15
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 594K $2.19M +$214K $3.68 28
2024 Q2 76.6M $313M -$53.7M $4.09 140
2024 Q1 85.1M $1.34B +$64.9M $15.76 137
2023 Q4 81.1M $1.23B +$4.82M $15.15 118
2023 Q3 80M $1.61B -$56.3M $20.06 134
2023 Q2 82.2M $2.32B +$443M $28.21 131
2023 Q1 67M $1.15B +$44.9M $17.20 108
2022 Q4 64.3M $1.3B +$105M $20.14 104
2022 Q3 58.8M $1.27B -$54.1M $21.66 115
2022 Q2 58.2M $1.64B +$359M $28.10 114
2022 Q1 44.4M $2.05B +$49.1M $46.14 126
2021 Q4 43M $3.61B +$90M $84.06 134
2021 Q3 41.2M $2.75B +$115M $66.64 114
2021 Q2 39.7M $2.11B +$206M $53.20 119
2021 Q1 36.3M $1.58B -$56M $43.39 92
2020 Q4 37.3M $1.94B +$309M $51.94 103
2020 Q3 31.6M $1.03B +$170M $32.69 65
2020 Q2 26.9M $1.28B +$1.28B $48.02 61